Medical School Harvard Medical School Graduated: 1983 Medical School Children's Hospital Boston Graduated: 1983 Medical School Childrens Hospital Graduated: 1983
National Cancer Institute (Nci)
Director, Division of Cancer Epidemiology and Genetics
Nci/Nih 2007 - 2013
Chief, Laboratory of Translational Genomics
Education:
Harvard Medical School 1979 - 1983
Doctor of Medicine, Doctorates
Princeton University 1974 - 1978
Bachelors, Bachelor of Arts, Music
Sidwell Friends School 1960 - 1974
Skills:
Genetics Genomics Cancer Translational Medicine Molecular Biology Cancer Research Cell Biology Drug Discovery Cell Culture Bioinformatics Biochemistry Lifesciences
Patrick Gilles - Carlsbad CA, US Patrick Dillon - Carlsbad CA, US David Wu - La Jolla CA, US Charles Foster - Silver Spring MD, US Stephen Chanock - Bethesda MD, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
A rapid assay for single nucleotide polymorphism (SNP) detection that utilizes electronic circuitry on silicon microchips is disclosed. The method provides accurate discrimination of amplified DNA samples following electronic assisted transport, concentration, and attachment of DNA to selected electrodes (test sites). The test sites make up organized arrays of samples that are distinguished by using internal controls of dual labeled reporters comprising wild-type and mismatched sequences to validate the SNP genotype. This method has been used to discriminate the complex quadra-allelic SNP of mannose binding protein.
News
7 Years Before Diagnosis – Oxford Scientists Discover Key to Early Cancer Detection
in, Joana Borlido, Xinmeng J. Mu, Adam Butterworth, Xia Shen, Jim Wilson, Themistocles L. Assimes, Rayjean J. Hung, Christopher Amos, Mark Purdue, Nathaniel Rothman, Stephen Chanock, Ruth C. Travis, Mattias Johansson and Anders Mlarstig, 29 April 2024, Nature Communications. DOI: 10.1038/s41467-024
Date: May 24, 2024
Category: Health
Source: Google
Would you have your DNA tested to predict how hard COVID-19 would strike? Should you?
ey also question whether its predictions are reliable for people infected with new SARS-CoV-2 variants. Itsa good start, but by no means is it calibrated or validated sufficiently to say this is a test I would take or my wife should take, says cancer geneticist Stephen Chanock of the U.S. Nation
Date: Jun 07, 2021
Category: More news
Source: Google
Youtube
Frontiers in Oncology - Stephen Chanock, MD
"Using Genomics to Investigate Radiation-relate... Issues Following t...
Duration:
1h 23s
TCGA: Status Report and Insights From Leaders...
November 27-28, 2012 - The Cancer Genome Atlas' 2nd Annual Scientific ...
Duration:
16m 3s
Dr Stephen Chanock, Division of Cancer Epidem...
Dr Stephen Chanock, Director of the Division of Cancer Epidemiology & ...
Duration:
29m 15s
Seminars in Genomic Medicine: Dr Stephen Chan...
On the 2nd Feb 2016, Dr Stephen Chanock gave a talk on the 'Complexity...
Duration:
57m 13s
Topic 2: Addressing Basic Research Questions ...
As one of a series of activities devoted to strategic planning, NHGRI ...
Duration:
9m 37s
IEU Seminar: Stephen Chanock
Radiation, genomic alterations in papillary thyroid carcinoma and tran...